EU turns to BioNTech/Pfizer after J&J vaccine suspension
Worm infections leave African women more vulnerable to STIs
14 April 2021In pig brain development, nature beats nurture
14 April 2021EU turns to BioNTech/Pfizer after J&J vaccine suspension
The EU is turning more heavily to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for longer-term needs to fight the mutating coronavirus, its chief Ursula von der Leyen said Wednesday.
